Cardio Diagnostics Holdings CDIO
NASDAQ CDIO
$1.90 +0.03 (+1.60%)
At close: Sep 30, 2026 · 4:00 PM EDT

Cardio Diagnostics Holdings (CDIO) Preferred Stock Liabilities (2021 - 2022)

Updated

Cardio Diagnostics Holdings (CDIO) recorded Preferred Stock Liabilities of $65.52 million in Q3 2022, up 0.8% from the prior quarter.

Analysis

Cardio Diagnostics Holdings (CDIO) Preferred Stock Liabilities (2021 - 2022) Analysis & Trends

At the end of FY2021, Cardio Diagnostics Holdings reported Preferred Stock Liabilities of $65 million.

  • Per Business Quant, the preceding three quarters came in at $65 million (Q2 2022), $65 million (Q1 2022) and $65 million (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Cardio Diagnostics Holdings 5.62 Mn -18.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 65.52 Mn
Jun 30, 2022 65.00 Mn
Mar 31, 2022 65.00 Mn
Dec 31, 2021 65.00 Mn
API Access

Cardio Diagnostics Holdings Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CDIO&period=max&api_key=YOUR_API_KEY